These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Findings with cis-Z-clopenthixol in the treatment of acute mania and schizophrenia. König P, Seifert T, Eberhardt G. Pharmacopsychiatry; 1986 Nov; 19(6):424-8. PubMed ID: 3797470 [Abstract] [Full Text] [Related]
4. A double-blind controlled study of intramuscular zuclopenthixol acetate and liquid oral haloperidol in the treatment of schizophrenic patients with acute exacerbation. Chouinard G, Safadi G, Beauclair L. J Clin Psychopharmacol; 1994 Dec; 14(6):377-84. PubMed ID: 7884017 [Abstract] [Full Text] [Related]
8. Zuclopenthixol acetate in Viscoleo--a new drug formulation. An open Nordic multicentre study of zuclopenthixol acetate in Viscoleo in patients with acute psychoses including mania and exacerbation of chronic psychoses. Amdisen A, Nielsen MS, Dencker SJ, Fensbo C, Ahlfors UG, Gravem A, Baastrup PC, Bjerkenstedt L, Gunby B, Wiesel FA. Acta Psychiatr Scand; 1987 Jan; 75(1):99-107. PubMed ID: 2883816 [Abstract] [Full Text] [Related]
9. Clinical and pharmacokinetic evaluation of zuclopenthixol acetate in Viscoleo. Balant LP, Balant-Gorgia AE, Eisele R, Reith B, Gex-Fabry M, Garrone G. Pharmacopsychiatry; 1989 Nov; 22(6):250-4. PubMed ID: 2575763 [Abstract] [Full Text] [Related]